Marshall Wace, LLP Exact Sciences Corp Transaction History

Marshall Wace, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $61.1 Million - $92.7 Million	975,054 New	975,054 $91.6 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $883,043 - $1.36 Million	27,621 Added 445.36%	33,823 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $220,853 - $472,778	6,202 New	6,202 $245,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $230,642 - $330,737	-4,007 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $8.29 Million - $11.5 Million	-114,413 Reduced 96.62%	4,007 $312,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $10.5 Million - $14.5 Million	116,684 Added 6721.43%	118,420 $11.3 Million
Q2 2021 Aug 13, 2021	SELL	$93.66 - $139.27 $2.34 Million - $3.48 Million	-25,014 Reduced 93.51%	1,736 $216,000
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $16.2 Million - $21.5 Million	-138,651 Reduced 83.83%	26,750 $3.53 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $16.5 Million - $23.5 Million	165,401 New	165,401 $21.9 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $2.62 Million - $4.36 Million	-46,963 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $725,406 - $2 Million	19,140 Added 68.79%	46,963 $2.72 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $2.16 Million - $2.78 Million	27,823 New	27,823 $2.57 Million
Q1 2019 May 14, 2019	SELL	$61.98 - $96.5 $431,628 - $672,026	-6,964 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $390,262 - $575,644	6,964 New	6,964 $439,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.